The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
出版年份 2013 全文链接
标题
The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
作者
关键词
NSAIDs, Microglia, Tau, Complement, Biomarkers, CSF, Positron emission tomography
出版物
ACTA NEUROPATHOLOGICA
Volume 126, Issue 4, Pages 479-497
出版商
Springer Nature
发表日期
2013-09-19
DOI
10.1007/s00401-013-1177-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 2013 Alzheimer's disease facts and figures
- (2013) Alzheimers & Dementia
- Mediterranean Diet, Cognitive Function, and Dementia
- (2013) Ilianna Lourida et al. EPIDEMIOLOGY
- Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis' still alive?
- (2013) Haythum O Tayeb et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tau pathology and neurodegeneration
- (2013) Maria Grazia Spillantini et al. LANCET NEUROLOGY
- Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
- (2013) A. Prestia et al. NEUROLOGY
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
- (2013) Jon B Toledo et al. Alzheimers Research & Therapy
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
- (2012) Henrik Zetterberg ARCHIVES OF NEUROLOGY
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- The spectrum of disease in chronic traumatic encephalopathy
- (2012) Ann C. McKee et al. BRAIN
- Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
- (2012) David H. Cribbs CNS & Neurological Disorders-Drug Targets
- Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease
- (2012) Bruno P Imbimbo et al. Expert Review of Clinical Immunology
- Crude caffeine reduces memory impairment and amyloid β1–42 levels in an Alzheimer’s mouse model
- (2012) Yi-Fang Chu et al. FOOD CHEMISTRY
- Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease
- (2012) Sang-Ho Choi et al. JOURNAL OF NEUROCHEMISTRY
- Sting of Alzheimer's failures offset by upcoming prevention trials
- (2012) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Genetic association of CR1 with Alzheimer's disease: A tentative disease mechanism
- (2012) Lili-Naz Hazrati et al. NEUROBIOLOGY OF AGING
- Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex
- (2012) Moonhee Lee et al. NEUROBIOLOGY OF AGING
- Suspected limited efficacy of γ-secretase modulators
- (2012) Nobuto Kakuda et al. NEUROBIOLOGY OF AGING
- CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings
- (2012) T. T. Seppala et al. NEUROLOGY
- Vitamin D, cognition, and dementia: A systematic review and meta-analysis
- (2012) C. Balion et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified γ-Secretase Complexes
- (2012) Matthias Cacquevel et al. PLoS One
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data
- (2011) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- Cerebrospinal Fluid Profiles and Prospective Course and Outcome in Patients With Amnestic Mild Cognitive Impairment
- (2011) Ozioma C. Okonkwo ARCHIVES OF NEUROLOGY
- Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease
- (2011) Grazia D'Onofrio et al. Expert Opinion on Drug Discovery
- Complement receptor 1 (CR1) and Alzheimer's disease
- (2011) Helen Crehan et al. IMMUNOBIOLOGY
- Structural Basis of C-terminal β-Amyloid Peptide Binding by the Antibody Ponezumab for the Treatment of Alzheimer's Disease
- (2011) Sherry L. La Porte et al. JOURNAL OF MOLECULAR BIOLOGY
- Targets for AD treatment: conflicting messages from γ-secretase inhibitors
- (2011) Kumar Sambamurti et al. JOURNAL OF NEUROCHEMISTRY
- Developing β-secretase inhibitors for treatment of Alzheimer’s disease
- (2011) Arun K. Ghosh et al. JOURNAL OF NEUROCHEMISTRY
- Activation of α-secretase cleavage
- (2011) Rolf Postina JOURNAL OF NEUROCHEMISTRY
- Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease?
- (2011) Natalia N. Nalivaeva et al. JOURNAL OF NEUROCHEMISTRY
- Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease
- (2011) Maria I Fonseca et al. Journal of Neuroinflammation
- No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease
- (2011) Antje Hillmann et al. NEUROBIOLOGY OF AGING
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- Alzheimer's Disease: The Challenge of the Second Century
- (2011) D. M. Holtzman et al. Science Translational Medicine
- Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study
- (2010) Felix Bermejo-Pareja et al. BMC Neurology
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer Disease
- (2009) Weiming Xia et al. ARCHIVES OF NEUROLOGY
- The Perils of Alzheimers Drug Development
- (2009) Lon Schneider et al. Current Alzheimer Research
- Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
- (2009) David B Henley et al. EXPERT OPINION ON PHARMACOTHERAPY
- Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury
- (2009) Ann C. McKee et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein42 and up-regulates cytoskeletal protein expression
- (2009) Pao-Yuan Wang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
- (2009) Pieter Jelle Visser et al. LANCET NEUROLOGY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- Structure-neurotoxicity relationships of amyloid -protein oligomers
- (2009) K. Ono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The amyloid cascade hypothesis
- (2008) Amos D. Korczyn Alzheimers & Dementia
- Neprilysin: An Enzyme Candidate to Slow the Progression of Alzheimer's Disease
- (2008) Salim S. El-Amouri et al. AMERICAN JOURNAL OF PATHOLOGY
- Distinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain
- (2008) Joshua R. Steinerman et al. ARCHIVES OF NEUROLOGY
- Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
- (2008) Thomas Wisniewski et al. BMC NEUROSCIENCE
- Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice
- (2008) Ann C. McKee et al. BRAIN RESEARCH
- Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease
- (2008) Jun Zhou et al. JOURNAL OF NEUROCHEMISTRY
- Ibuprofen modifies cognitive disease progression in an Alzheimer’s mouse model
- (2008) D. Van Dam et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology
- (2008) Z. Arvanitakis et al. NEUROLOGY
- Protective effects of NSAIDs on the development of Alzheimer disease
- (2008) Steven C. Vlad et al. NEUROLOGY
- No advantage of A 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies
- (2008) C. A. Szekely et al. NEUROLOGY
- Amyloid- Dynamics Correlate with Neurological Status in the Injured Human Brain
- (2008) D. L. Brody et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now